Oaktree Acquisition Corp. III Life Sciences (OACCW) › Cash & EquivalentsOaktree Acquisition Corp. III Life Sciences (OACCW) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $1.36M2025: $1.43M$1.43M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.43M+5.7%2024$1.36M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share